New Journal of Chemistry p. 11607 - 11618 (2017)
Update date:2022-08-11
Topics:
Banerjee, Saikat
Brand?o, Paula
Bauzá, Antonio
Frontera, Antonio
Barceló-Oliver, Miquel
Panja, Anangamohan
Saha, Amrita
A novel mononuclear Mn(iii) complex, [MnIII(L1)Cl(H2O)]·H2O (1), and a tetranuclear Zn(ii)-Mn(ii) complex, [{ZnII2(L2)2Cl2}MnII2(μ1,1-N3)2(H2O)2]·2H2O (2), have been synthesized involving azo Schiff base ligands, viz. H2L1 = (E)-6,6′-((1E,1′E)-(ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-methoxy-4-((E)-p-tolyldiazenyl)phenol) and H2L2 = (E)-6,6′-((1E,1′E)-((2,2-dimethylpropane-1,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2-methoxy-4-((E)-p-tolyldiazenyl)phenol), respectively. The solid-state structures were determined by single crystal X-ray crystallography. In complex 1, the Mn(iii) centre adopts slightly distorted octahedral geometry, while in complex 2 the Mn(ii) centre residing in the outer core of the ligand adopts a distorted pentagonal bipyramidal geometry. In complex 1, the chloride ion simply acts as a terminal coligand, while in complex 2, azide ions bind the metal centres in an end-on bridging fashion to produce a tetranuclear complex. The phenoxazinone synthase-like activity of both complexes has been examined and a detailed investigation of the structure-property correlation has been performed. Whereas the mononuclear complex 1 exhibits significant phenoxazinone activity, complex 2 is almost inactive, although in both complexes labile sites are available at manganese centres for substrate binding. The present work therefore highlights the importance of higher oxidation states of manganese over nuclearity for the development of better in vitro catalysts. In addition, extensive efforts have been made to visualize and quantify all supramolecular interactions present in 1 and 2.
View MoreHANGZHOU EVC CHEMICAL CO.,LTD.(expird)
Contact:+86-571-88296056
Address:Room#3001,Zhejiang Chemical Market,No.10,Road Shenban,Hangzhou,Zhejiang,China
guide(suzhou) fine materials co. ltd
Contact:0512-80972173
Address:21st Building, No.369 Lushan Rd, New District Suzhou China 215129
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
website:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Changzhou Pesan Chemical Co.,Ltd
website:http://www.pesanchem.com
Contact:+86 021 61559630
Address:No.7-9,Guanghua St.,Zhonglou District,Changzhou,China
Doi:10.1002/cssc.201800670
(2018)Doi:10.1039/c7gc01116d
(2017)Doi:10.1016/j.ejps.2020.105466
(2020)Doi:10.1039/c7ta03786d
(2017)Doi:10.1016/j.ejmech.2017.04.027
(2017)Doi:10.1021/jm00159a009
(1986)